Myomo, Inc. (MYO)
NYSEAMERICAN: MYO · Real-Time Price · USD
2.260
+0.040 (1.80%)
Jun 27, 2025, 4:00 PM - Market closed
Myomo Market Cap
Myomo has a market cap or net worth of $81.31 million as of June 27, 2025. Its market cap has decreased by -17.03% in one year.
Market Cap
81.31M
Enterprise Value
68.06M
1-Year Change
-17.03%
Ranking
Category
Stock Price
$2.26
Market Cap Chart
Since June 30, 2017, Myomo's market cap has increased from $66.00M to $81.31M, an increase of 23.20%. That is a compound annual growth rate of 2.64%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 26, 2025 | 79.90M | -58.98% |
| Dec 31, 2024 | 194.80M | 46.69% |
| Dec 29, 2023 | 132.80M | 3,588.89% |
| Dec 30, 2022 | 3.60M | -92.34% |
| Dec 31, 2021 | 47.00M | 52.60% |
| Dec 31, 2020 | 30.80M | 492.31% |
| Dec 31, 2019 | 5.20M | -70.95% |
| Dec 31, 2018 | 17.90M | -21.83% |
| Dec 29, 2017 | 22.90M | -65.30% |
View and export this data all the way back to 2017.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 712.35B |
| Johnson & Johnson | 365.19B |
| AbbVie | 329.26B |
| Novo Nordisk | 301.06B |
| UnitedHealth Group | 273.59B |
| Novartis AG | 235.02B |
| Abbott Laboratories | 231.50B |
| AstraZeneca | 216.45B |